Skip to main content

Castle Biosciences Inc

CSTL
Exchange
Nasdaq
Industry
Services-Medical Laboratories
SEC CIK
0001447362

In the last 90 days, Castle Biosciences Inc insiders filed 0 open-market purchases and 20 sales; 176 institutions reported holding it in 13F filings for Q2 2026, worth $653.8M in total; no superinvestor holds it.

Superinvestors holding CSTL, Q2 2026

See all superinvestors

No superinvestor reported holding CSTL in Q2 2026.

Moves by quarter

Superinvestors that opened, added to, trimmed or sold out of CSTL each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.

  1. Q2 2022

    0 superinvestors holding at quarter end

    Sold out
    ARK Invest
  2. Q1 2022

    1 superinvestor holding at quarter end

    Reduced
    ARK Invest (−3.6%)
  3. Q4 2021

    1 superinvestor holding at quarter end

    Reduced
    ARK Invest (−41.0%)
  4. Q3 2021

    1 superinvestor holding at quarter end

    Reduced
    ARK Invest (−18.5%)
  5. Q2 2021

    1 superinvestor holding at quarter end

    Reduced
    ARK Invest (−2.8%)